Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore

Cordife appoints Mr Yiu Pang Fai (Ivan) as Group Chief Executive Officer

Cordlife to advance research on Mesenchymal Stem Cell Secretome-based products for the treatment of Osteoarthritis

Cordlife launches proprietary lifestyle genetic screening services in Indonesia

Cordlife launches new peripheral blood stem cell service in Singapore

Cordlife expands its global footprint to Cambodia

Cordlife Publishes Study Confirming Superiority of Strategic Partner’s Stem Cell Growth Media

Cordlife and AMILI partner to launch the first-ever gut microbiome banking service in Southeast Asia

Cordlife Hong Kong is accredited by AABB for 13 consecutive years

Stemlife Earns AABB Accreditation for the Third Consecutive Time

Cordlife Singapore expands suite of paediatric services with Earscreen^TM and Cordlife Talent Screening

Cordlife Indonesia extends stem cell cryopreservation service to leukaemia patients from Dharmais Cancer Hospital in support of cellular therapy

Cordlife’s Cord Blood Banking Facility in Philippines Attains AABB Accreditation Once Again

Cordlife Group Celebrates 20 Years Of Revolutionary Innovation Research

Cordlife’s Cord Blood Banking Facility in India Attains AABB and NABL Accreditation

SingHealth Duke-NUS Academic Medical Centre and Cordlife partner to advance stem cell technology to first-in-man clinical trial in Singapore

Cordlife launches OptiQ: A first-of-its-kind corneal lenticule banking service in Singapore

Cordlife’s Malaysia subsidiary, Stemlife, clinches The BrandLaureate World’s e-Branding Award

Cordlife supports clinical trials with donated umbilical cords and mesenchymal stem cell banking service in the Philippines

Cordlife’s Cord Blood Banking Facility in Singapore Attains AABB Accreditation for the Seventh Time

Cordlife Becomes First Cord Blood Bank in Indonesia to Achieve Global AABB Accreditation

Cordlife Group’s Subsidiary in the Philippines receives AABB Re-accreditation

Cordlife Extends Geographical Footprint to Bangladesh

Cordlife Opens the Largest Stem Cell Banking Facility in Indonesia

Cordlife’s South Korea Partner EDGC Receives CAP Accreditation For Its Proprietary NIPT Services

ONE BLOOD, a Stemlife CSR programme

Cordlife Launches Genetic Testing Service in the Philippines to Help Families Prevent and Manage Hereditary Conditions

Singapore’s Tripartite Alliance for Fair and Progressive Employment Practices Recognises Cordlife as a Human Capital Partner

Cordlife Earns Prestigious AABB Accreditation in Malaysia; Singapore and Hong Kong Facilities Re-accredited

Cordlife Advances Preventive Healthcare in Singapore with The Launch of New Genetic Testing Service

Singapore Children’s Society Appreciates Cordlife for Its Role in 1000 Enterprises for Children-in-Need Fundraiser

Cordlife Partners US-Based PlumCare to Offer Genetic Screening for Disease Management and Prevention

Cordlife launches NICE®, a clinically approved non-invasive prenatal test in Indonesia and Philippines

Cordlife Named Among Top Award Recipients At Investor Relations Website Survey 2017

Cordlife Holds Official Opening Ceremony in Myanmar

Cordlife Group’s Subsidiary is First Cord Blood Bank in Philippines to Earn Prestigious AABB Accreditation

Cordlife Extends Asia Footprint to Vietnam with Appointment of Marketing Agent

CellResearch Corporation Extends Umbilical Cord Tissue Banking Services Across the US through Partnership with University of Colorado, Anschutz Medical Campus and CariCord

Cordlife Group Received Accreditation from College of American Pathologists for its Hong Kong and India Subsidiaries

Cordlife Appoints Marketing Agent in Myanmar

Cordlife Raised Cord Blood Awareness in Singapore Doctors via Leading US Experts

Cordlife is now one out of the six private cord blood banks worldwide that is double-accredited and the first in SEA to achieve the dual-accreditation status.

Cordlife Honoured As One Of Forbes Asia's "Best Under a Billion" Companies.

Cordlife Named As Runner-Up In The Mid And Small Category Of The 16th SIAS Investors’ Choice Awards - Singapore Corporate Governance Awards 2015

Cordlife Wins 2015 Frost & Sullivan Singapore Stem Cell Banking Company of the Year Award

Cordlife Partners with Leading Neurologist on Study In Child Autism Using Own Cord Blood Stem Cells

Cordlife Group Limited and China Cord Blood Corporation Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy

Cordlife to assist autistic children in Singapore to participate in groundbreaking Duke Medicine Trial

Cordlife India Obtains AABB Accreditation

CordLife To Invest $1 Million In Strategic Talent Management To Support Its Rapid Growth

Asia's First Cord Blood Stem Cell Transplant to Treat Cerebral Palsy

CordLife Introduces Advanced Human Stem Cell Technology in Hong Kongn

康盛人生（CordLife）在香港引進最尖端臍帶儲存科技

Philippines' First Cord Blood Processing and Cryopreservation Facility Opens

康盛人生策略性進入中國市場

CordLife secures strategic presence in China

康盛人生提供臍帶血治療腦痳痺成新加坡醫學界先例

CordLife released cord blood to treat cerebral palsy, a medical first in Singapore

CordLife's Business Expansion Brings Hope to Diabetic Patients in India

康盛人生收集澳門政府醫院首份臍帶血樣本

Homegrown CordLife makes headway into China

Updates on CordLife operations in the Philippines

Cord Blood Banking Giant CordLife To Develop Stem Cell Therapies with the Most Advanced Facility in India

康盛人生全港首推世界推崇的自動化臍血處理系統

CordLife First in Hong Kong to Implement World's Most Preferred Automated Cord Blood Processing

CordLife Opens Medan Representative Office to Meet Growing Demands

CordLife is first to present the standard in cord blood banking in Singapore and Asia

CordLife Cares' first beneficiary is leukaemia boy's family

CordLife posts strong revenue growth and achieves first positive EBITDA for FY08

CordLife Opens Second Office To Serve Soaring HK Birth Rate

CordLife posts revenue increase of 56% in FY08

CordLife Opens New India Cord Blood Facility

CordLife Opens New Jakarta Cord Blood Facility

Investor News

CordLife Hong Kong Achieves ISO 9001:2000 Certification

CordLife Completes Technology Restructuring

CordLife gets approval & license from Indonesian government

Cordlife to rationalise technology and product development activities, to further focus on cord blood banking business

CyGenics Ltd becomes CordLife Ltd

CyGenics Appoints New Directors

CyGenics Recognized by World Economic Forum

A Healthcare Company Focused On Tissue & Cord Blood Banking

CyGenics Signs Collaboration Agreement with the Blood Centre of Zhejiang Province

CyGenics on Track to Launch Cord Blood Banking Services in India in 2007

CyGenics Acquires Stake in DNAPro in Exchange for Cell Sciences Subsidiary

CordLife Indonesia Officially Launched

Annual Report

CyGenics Adds Strategic Indonesian JV to Revenue Growth Plan

CyGenics to focus on tissue and cord blood banking

CyGenics Acquires Stake in DNAPro in Exchange for Cell Sciences Subsidiary

CyGenics Expands into Revenue Generating Clinical Cell Therapy

First Cystic Fibrosis Cord Blood Collection

CyGenics Expands Into Europe

CyGenics CEO Reappointed BioSingapore Chairman

CyGenics Awarded An other Patent

CyGenics reports strong revenue growth

CyGenics Half Year Report

NTUC to provide insurance policy for CordLife customers

CyGenics Appoints Ex-Baxter International Senior Executive As New Board Member

CyGenics in International Cancer Therapy Collaboration

CyGenics Expands Cord Blood Banking Into India

ROI, Resource Allocation and Risk Management Review

CyGenics’ Subsidiary to Distribute Bird Flu Test Kits

CyGenics Appoints Chief Scientific Officer

CyGenics’ Subsidiary Signs Distribution Agreement

CyGenics T cell Clinical Trials Update

CyGenics to list CordLife

CyGenics and Johns Hopkins University Sign Research Agreement

CyGenics takes 51% equity in an Australian cord blood banking business

Annual Report

Cord Blood Misconceptions Dispelled

CordLife is Southeast Asia’s First AABB Accredited Cord Blood Bank

CyGenics reports a 40 per cent increase in revenue

CyGenics Quarterly Newsletter August 2005

CyGenics Quarterly Newsletter August 2005

Change Of Director's Interest Notice

Manager of Company Announcements Australian Stock Exchange

CyGenics forms new US subsidiary CytoVations to acquire and develop cell technology

CyGenics strengthens Melbourne operations

Manager of Company Announcements Australian Stock Exchange

CordLife Opens Banking Facility in Hong Kong - Regional cord blood bank company sets up full operations in the SAR

CyGenics Granted Key Patent for the China Market

Cygenics Secures Exclusive Licence on Enhanced T Cell Production Technologies

US Department of Defense Renews Contract with Cytomatrix

Cordlife Opens Second Tissue Processing and Storage Facitlity In Singapore

CyGenics’ T-cell Clinical Trials

CyGenics Strengthens Global Growth with Key Appointment

Change Of Director's Interest Notice

Cell Sciences signs Memorandum of Understanding (MOU) with Corning Life Sciences

CyGenics

CyGenics Ltd and Cell Therapies to Collaborate on T-cell Clinical Trials

CordLife Raises $7 Million in Series B Funding

CyGenics Meets Key Milestone: Files IND for T-cell Clinical Trials

CyGenics secures exclusive licence on enhanced T cell production technologies from the Brigham and Women’s Hospital Exclusive worldwide licence from Harvard Medical School teaching affiliate

CordLife Opens Second Tissue Processing and Storage Facility in Singapore

CyGenics On Track

CyGenics and the Murdoch Childrens Research Institiute to Callaborate on Stem Cell Expansion Trails

CYGENICS LTD SHARE TRADING POLICY FOR EMPLOYEES AND DIRECTORS

Quarterly report for entities admitted on the basis of commitments

National Institutes of Healthnews US$272,000 Cygenics Contract

Cord Blood Stem Cells Transplant a Success

Cygenics IPO oversubscribed

CyGenics To List on Australian Stock Exchange

Cordlife Aims for Future Growth as Cygenics

Cell Sciences Signs On European Distributor

Preliminary Final Report

Asian Cord Blood Banks Form Consortium

CyGenics secures exclusive licence on enhanced T cell production technologies from the Brigham and Women’s Hospital

CordLife Sets Up Cell Sciences Pte Ltd

CordLife Secures US Department of Defense Contract

CordLife Raises $7 Million in Series B Funding

Cordlife CEO Receives Spirit of Enterprise Award

CORDLIFE APPOINTS SEASONED BUSINESSMAN, RICHARD CHUNG, CHAIRMAN

CordLife launches peripheral blood stem cell processing and banking services

Cordlife / Cytomatrix in the spotlight with introduction of new range of disposable dynamic cell growth systems

Singapore - based CordLife Acquires US based Cytomatrix

CordLife launches Business Partnership Programme to expand operations globally

Local Cord Blood Technology Company sets up State-of-the-Art R&D and Process Development Laboratory Facilities

Singapore Company First to Set Up Cord blood Bank in Shenyang, China

Providing A Life Line Of Hope

Singapore Company First To Set Up Cord Blood Bank In Shenyang, China